Pentokey Organy (India) Limited (BOM:524210)
27.58
-1.31 (-4.53%)
At close: Nov 16, 2026
Pentokey Organy (India) Revenue
Pentokey Organy (India) had revenue of 1.93M INR in the quarter ending September 30, 2026, a decrease of -80.40%. This brings the company's total for the last twelve months to -38.25M. In the fiscal year ending March 31, 2026, Pentokey Organy (India) had annual revenue of 20.90M with 152.98% growth. That makes Pentokey Organy (India) the 48,173rd largest company in the world by revenue and 5,524th in India.
Revenue (ttm)
-38.25M
Revenue Growth
+152.98%
P/S Ratio
n/a
Revenue / Employee
-12.75M
Employees
3
Market Cap
173.00M
Revenue by Geography
- India 19.44M 93.0%
- Export 1.46M 7.0%
Fiscal year ended Mar 31, 2026 See the full Pentokey Organy (India) breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 20.90M | 12.64M | 152.98% |
| Mar 31, 2025 | 8.26M | -35.70M | -81.21% |
| Mar 31, 2024 | 43.96M | 308.00K | 0.71% |
| Mar 31, 2023 | 43.66M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Chandra Bhagat Pharma | 1.74B |
| Dipna Pharmachem | 1.31B |
| Medico Intercontinental | 864.77M |
| Medistep Healthcare | 731.36M |
| Zenlabs Ethica | 485.60M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |